In breast cancer, FRA-1 expression is associated with the transition from normal epithelium to hyperplasia/ductal carcinoma in situ (DCIS) [14–16] and elevated FRA-1 correlates with increasing grade in invasive ductal carcinoma [2, 16]. The gene discussed is FOSL1; the disease is ductal breast carcinoma in situ.